1. Home
  2. MIGI vs GOVX Comparison

MIGI vs GOVX Comparison

Compare MIGI & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mawson Infrastructure Group Inc.

MIGI

Mawson Infrastructure Group Inc.

N/A

Current Price

$2.69

Market Cap

4.8M

Sector

Finance

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

N/A

Current Price

$1.87

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MIGI
GOVX
Founded
2012
2001
Country
United States
United States
Employees
N/A
17
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.0M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
MIGI
GOVX
Price
$2.69
$1.87
Analyst Decision
Hold
Buy
Analyst Count
1
2
Target Price
N/A
$200.00
AVG Volume (30 Days)
46.6K
129.8K
Earning Date
04-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.90
N/A
EPS
N/A
N/A
Revenue
$43,571,720.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.12
52 Week High
$15.80
$4.40

Technical Indicators

Market Signals
Indicator
MIGI
GOVX
Relative Strength Index (RSI) 36.62 51.49
Support Level $0.39 $0.55
Resistance Level $3.50 $4.40
Average True Range (ATR) 0.25 0.20
MACD 0.01 0.01
Stochastic Oscillator 15.12 88.89

Price Performance

Historical Comparison
MIGI
GOVX

About MIGI Mawson Infrastructure Group Inc.

Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: